当前位置: X-MOL 学术bioRxiv. Biochem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery of potent inhibitors of PLproCoV2 by screening libraries of selenium-containing compounds
bioRxiv - Biochemistry Pub Date : 2020-05-21 , DOI: 10.1101/2020.05.20.107052
Ewelina Węglarz-Tomczak , Jakub M. Tomczak , Mirosław Giurg , Małgorzata Burda-Grabowska , Stanley Brul

A collection of twelve organoselenium compounds, structural analogues of antioxidant drug ebselen were screened for inhibition of the papain-like protease (PLpro) from the acute respiratory syndrome coronavirus 2 (SARS-CoV-2, CoV2). This cysteine protease, being responsible for the hydrolysis of peptide bonds between specific amino acids, plays a critical role in CoV2 replication and in assembly of new viral particles within human cells. The activity of the PLpro CoV2 is essential for the progression of coronavirus disease 2019 (COVID-19) and it constitutes a key target for the development of anti-COVID-19 drugs. Here, we identified four strong inhibitors that bind favorably to the PLpro CoV2 with the IC50 in the nanomolar range.

中文翻译:

通过筛选含硒化合物的文库发现PLproCoV2的有效抑制剂

筛选了十二种有机硒化合物(抗氧化剂药物ebselen的结构类似物)以抑制来自急性呼吸系统综合症冠状病毒2(SARS-CoV-2,CoV2)的木瓜蛋白酶(PL pro)。这种半胱氨酸蛋白酶负责水解特定氨基酸之间的肽键,在CoV2复制和人类细胞内新病毒颗粒的组装中起关键作用。PL pro CoV2的活性对于2019年冠状病毒疾病(COVID-19)的发展至关重要,它构成了抗COVID-19药物开发的关键目标。在这里,我们确定了四种强抑制剂,它们以纳摩尔范围的IC 50与PL pro CoV2良好结合。
更新日期:2020-05-21
down
wechat
bug